Treatments using a dual carrier immunogenic construct vaccine of a primary carrier molecule less than 70KD conjugated to a secondary carrier comprising A T-dependent antigen

摘要

This dual carrier immunogenic construct for use in a vaccine comprises; a)at least one primary carrier of greater than 70kDa Mr; b) at least one secondary carrier comprising a T-dependent antigen conjugated to a primary carrier; and c) a pharmaceutically acceptable carrier.